Navigation Links
Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
Date:6/4/2009

Thursday, June 11th, 10:00 a.m. EDT

WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, June 11th, 2009 at 10:00 a.m. EDT, to report fourth quarter and fiscal year 2009 financial results and to provide a quarterly update of the Company.

This call is being webcast by Thomson/CCBN and can be accessed via Repligen's website at www.repligen.com. If you are unable to access the webcast via the internet, you may also listen to the live broadcast by calling (800) 295-4740 for domestic calls and (617) 614-3925 for international calls. Participants must provide the following passcode: 30164372. For those who cannot participate in the live conference call, an archive of the audio webcast will be available shortly after the call and may be accessed at www.repligen.com.

About Repligen Corporation

Repligen Corporation is a biopharmaceutical company focused on the development of novel therapeutics for neurological disorders. In addition, we are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
2. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
3. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
4. Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
5. Repligen Receives Research Grants to Support Friedreichs Ataxia Development Program
6. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
7. Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT
8. Repligen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference Monday, November 10th, 4:55 p.m. EST
9. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
10. Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
11. Repligen Reports Third Quarter Fiscal Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... YARDLEY , Pennsylvanie, 18 septembre 2014 ... Lyon en 1974, a été ... à compléter les évaluations cliniques traditionnelles par ... Reported Outcomes) et sur les impacts économiques ... http://photos.prnewswire.com/prnh/20140618/119365 A cours ...
(Date:9/18/2014)... , Sept. 18, 2014   Sigma-Aldrich ... it has entered into a new gene editing ... School,s Vector Core. Under the partnership, Sigma-Aldrich will ... experimental design consultation, and dedicated gene editing bioinformaticians. ... gene editing-based research at the U-M Medical School. ...
(Date:9/18/2014)... September 18, 2014 OMICS Group ... globe to participate in the ‘Open Access Week’ ... to OMICS Group Pharma Journals from ... of the fastest emerging Sciences, accelerating with a ... services across the globe. The industry is gearing ...
(Date:9/18/2014)... MA (PRWEB) September 18, 2014 ... Molecule Sequencing (tSMS™) technology, announced today the closing ... of investment, led by Genomic Diagnostic Technologies, will ... and diagnostic applications. , Founded in March 2013 ... and Bioinformatics Analyst at Helicos BioSciences, SeqLL has ...
Breaking Biology Technology:1974 - 2014 - Mapi fête ses 40 ans 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2
... ROMAINVILLE, France, March 13 ,Cellectis SA (NYSE: ... rational genome engineering,has announced today that it ... Inc. in the United States District Court ... lawsuit seeks a declaration that,by making and ...
... pm ET today, BEDMINSTER, N.J., March 13 ... reported 2007 financial results,and accomplishments that reflected the ... late-stage product candidates in specialty,indications for gastrointestinal and ... line with its new business plan, during 2007 ...
... IV Patent Challenge Underway -, CORONA, Calif., ... ), a leading specialty pharmaceutical,company, today confirmed that ... with the U.S. Food and Drug Administration (FDA) ... tablets, USP,(0.09 mg/0.02 mg) extended-cycle oral contraceptive product ...
Cached Biology Technology:Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 2Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 3Cellectis Sues Precision BioSciences for Infringement of its Patents Concerning Meganuclease Technology 4NPS Pharmaceuticals Reports 2007 Financial Results 2NPS Pharmaceuticals Reports 2007 Financial Results 3NPS Pharmaceuticals Reports 2007 Financial Results 4NPS Pharmaceuticals Reports 2007 Financial Results 5NPS Pharmaceuticals Reports 2007 Financial Results 6NPS Pharmaceuticals Reports 2007 Financial Results 7NPS Pharmaceuticals Reports 2007 Financial Results 8NPS Pharmaceuticals Reports 2007 Financial Results 9Watson Files FDA Application for Generic LYBREL(R) 2
(Date:9/18/2014)... it that when people are too stressed they are ... the Brain Mind Institute (BMI) at EPFL have just ... between chronic stress and the loss of social skills ... attacks a synaptic regulatory molecule in the brain. This ... Communications . , Carmen Sandi,s team went to ...
(Date:9/18/2014)... the ideal animal in which to study the genes ... into tens of thousands of freshwater streams and lakes ... adapt to the new environment. , Breeding studies between ... up one of the genes that controls tooth number, ... regulation in a freshwater population is associated with a ...
(Date:9/18/2014)... is probably the ultimate form of camouflage: you don,t ... this strategy is not as uncommon as you might ... County, USA, explains that the larval life stages of ... part of the anatomy that most creatures cannot make ... have to shield each individual eye unit with an ...
Breaking Biology News(10 mins):How stress tears us apart 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Transparent larvae hide opaque eyes behind reflections 2
... a new biological pathway-based computational model, called the Pathway-based ... between different diseases as reported in BioDataMining ... present in large publicly available disease datasets to find ... a visual form. "The PHPN offers a bird,s ...
... 11 million people suffer severe burns. The resulting large, deep ... lifelong scars. What is needed to reduce this kind of ... very limited area of skin can be removed from the ... Besides conventional skin grafting, another option is to engineer a ...
... to finding cures for heart disease scientists are working to ... a tissue model for the human heart that can bridge ... exist for other organs, but for the heart, this has ... embryonic stem cells with the resulting muscle having significant similarities ...
Cached Biology News:Dartmouth researchers develop new tool to identify genetic risk factors 2Blood and lymphatic capillaries grown for the first time in the lab 2Scientists develop an engineered cardiac tissue model to study the human heart 2
... PCR Purification Kits provide rapid and efficient ... PCR products, and salts from PCR products ... provides two Binding Buffer options for ... can be performed in either single column ...
Mus musculus junctophilin 2 (Jph2) Antigen: Recombinant Protein...
... Cloning Kits for Sequencing allow 5-minute cloning and ... TOPO Cloning vectors with primer sites located as ... product insertion site. This minimizes the amount of ... reaching the sequence of your insert.vectors are available. ...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Biology Products: